121 related articles for article (PubMed ID: 18930764)
1. Attenuation of high sweet solution preference by mood stabilizers: a possible mouse model for the increased reward-seeking domain of mania.
Flaisher-Grinberg S; Overgaard S; Einat H
J Neurosci Methods; 2009 Feb; 177(1):44-50. PubMed ID: 18930764
[TBL] [Abstract][Full Text] [Related]
2. A possible utilization of the mice forced swim test for modeling manic-like increase in vigor and goal-directed behavior.
Flaisher-Grinberg S; Einat H
J Pharmacol Toxicol Methods; 2009; 59(3):141-5. PubMed ID: 19341808
[TBL] [Abstract][Full Text] [Related]
3. Proposing the sweet solution preference test as a screening assay for anti-manic effects of mood stabilizers.
Kara N; Flaisher-Grinberg S; Einat H
J Neurosci Methods; 2020 Dec; 346():108920. PubMed ID: 32937157
[TBL] [Abstract][Full Text] [Related]
4. Strain-specific battery of tests for domains of mania: effects of valproate, lithium and imipramine.
Flaisher-Grinberg S; Einat H
Front Psychiatry; 2010; 1():10. PubMed ID: 21423422
[TBL] [Abstract][Full Text] [Related]
5. Antimanic efficacy of retigabine in a proposed mouse model of bipolar disorder.
Dencker D; Husum H
Behav Brain Res; 2010 Feb; 207(1):78-83. PubMed ID: 19815032
[TBL] [Abstract][Full Text] [Related]
6. Modeling mania: Further validation for Black Swiss mice as model animals.
Hannah-Poquette C; Anderson GW; Flaisher-Grinberg S; Wang J; Meinerding TM; Einat H
Behav Brain Res; 2011 Sep; 223(1):222-6. PubMed ID: 21570428
[TBL] [Abstract][Full Text] [Related]
7. Partial effects of the protein kinase C inhibitor chelerythrine in a battery of tests for manic-like behavior in black Swiss mice.
Einat H
Pharmacol Rep; 2014 Aug; 66(4):722-5. PubMed ID: 24948079
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a battery of simple models for facets of bipolar disorder: a practical approach to achieve increased validity, better screening and possible insights into endophenotypes of disease.
Einat H
Behav Genet; 2007 Jan; 37(1):244-55. PubMed ID: 16865528
[TBL] [Abstract][Full Text] [Related]
9. Behavioral differences in black Swiss mice from separate colonies: implications for modeling domains of mania.
Juetten J; Einat H
Behav Pharmacol; 2012 Apr; 23(2):211-4. PubMed ID: 22193594
[TBL] [Abstract][Full Text] [Related]
10. The effects of the atypical antipsychotic asenapine in a strain-specific battery of tests for mania-like behaviors.
Ene HM; Kara NZ; Einat H
Behav Pharmacol; 2015 Jun; 26(4):331-7. PubMed ID: 25590966
[TBL] [Abstract][Full Text] [Related]
11. Re-examination of amphetamine-induced conditioned suppression of tastant intake in rats: the task-dependent drug effects hypothesis.
Huang AC; Hsiao S
Behav Neurosci; 2008 Dec; 122(6):1207-16. PubMed ID: 19045940
[TBL] [Abstract][Full Text] [Related]
12. Different behaviors and different strains: potential new ways to model bipolar disorder.
Einat H
Neurosci Biobehav Rev; 2007; 31(6):850-7. PubMed ID: 17307253
[TBL] [Abstract][Full Text] [Related]
13. Partial effects of the AMPAkine CX717 in a strain specific battery of tests for manic-like behavior in black Swiss mice.
Kara NZ; Flaisher-Grinberg S; Einat H
Pharmacol Rep; 2015 Oct; 67(5):928-33. PubMed ID: 26398387
[TBL] [Abstract][Full Text] [Related]
14. Peripheral ghrelin enhances sweet taste food consumption and preference, regardless of its caloric content.
Disse E; Bussier AL; Veyrat-Durebex C; Deblon N; Pfluger PT; Tschöp MH; Laville M; Rohner-Jeanrenaud F
Physiol Behav; 2010 Sep; 101(2):277-81. PubMed ID: 20515700
[TBL] [Abstract][Full Text] [Related]
15. Effects of mood stabilizers on brain reward processes in rats: studies using the intracranial self-stimulation paradigm.
Mavrikaki M; Nomikos GG; Panagis G
Eur Neuropsychopharmacol; 2009 Mar; 19(3):205-14. PubMed ID: 19110403
[TBL] [Abstract][Full Text] [Related]
16. Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania.
Kalinichev M; Dawson LA
Int J Neuropsychopharmacol; 2011 Sep; 14(8):1051-67. PubMed ID: 21208504
[TBL] [Abstract][Full Text] [Related]
17. Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain.
Jornada LK; Moretti M; Valvassori SS; Ferreira CL; Padilha PT; Arent CO; Fries GR; Kapczinski F; Quevedo J
J Psychiatr Res; 2010 Jun; 44(8):506-10. PubMed ID: 19954800
[TBL] [Abstract][Full Text] [Related]
18. Effects of mood stabilizers on DNA damage in an animal model of mania.
Andreazza AC; Kauer-Sant'Anna M; Frey BN; Stertz L; Zanotto C; Ribeiro L; Giasson K; Valvassori SS; Réus GZ; Salvador M; Quevedo J; Gonçalves CA; Kapczinski F
J Psychiatry Neurosci; 2008 Nov; 33(6):516-24. PubMed ID: 18982174
[TBL] [Abstract][Full Text] [Related]
19. Drug interactions of lithium and other antimanic/mood-stabilizing medications.
Dunner DL
J Clin Psychiatry; 2003; 64 Suppl 5():38-43. PubMed ID: 12720483
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of DeltaFosB is associated with attenuated cocaine-induced suppression of saccharin intake in mice.
Freet CS; Steffen C; Nestler EJ; Grigson PS
Behav Neurosci; 2009 Apr; 123(2):397-407. PubMed ID: 19331462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
